Pages that link to "Q45148146"
Jump to navigation
Jump to search
The following pages link to Serological immunomarkers in cutaneous T cell lymphoma (Q45148146):
Displaying 15 items.
- Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma (Q28071331) (← links)
- Posttranslational modifications of transthyretin are serum markers in patients with mycosis fungoides (Q33280777) (← links)
- Proteome-based analysis of serologically defined tumor-associated antigens in cutaneous lymphoma (Q33519571) (← links)
- Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas. (Q35686954) (← links)
- Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins (Q35751101) (← links)
- Cutaneous malignant lymphomas: update 2006. (Q36642858) (← links)
- Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies (Q36707344) (← links)
- Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review (Q36956380) (← links)
- Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome (Q37688819) (← links)
- Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome (Q38765889) (← links)
- The biomarker landscape in mycosis fungoides and Sézary syndrome (Q39023382) (← links)
- Elevated soluble urokinase receptors in focal segmental glomerulosclerosis: a role for IL-2? (Q53278469) (← links)
- Pruritus: Progress toward Pathogenesis and Treatment. (Q55076872) (← links)
- Effect of Kang'ai Injection on serum level of soluble interleukin-2 receptor and vascular endothelial growth factor in patients with esophageal carcinoma during radiotherapy (Q79955521) (← links)
- Angiogenesis in cutaneous T-cell lymphoma - proteomic approaches (Q92831733) (← links)